Tag: surgical hemostats market research

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Surgical Hemostats Market Projected To Reach By 2030?

The surgical hemostats market size has demonstrated strong expansion in recent years. This market is set to increase from $3.93 billion in 2025 to $4.2 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.9%. The market’s historical development can be ascribed to an increase in surgical procedures, the necessity for blood loss management, innovations in surgical instruments, an expansion of hospital infrastructure, and greater awareness regarding patient safety.

The surgical hemostats market is anticipated to undergo substantial expansion in the upcoming years. It is projected to achieve a size of $5.41 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.5%. The expansion during this forecast timeframe can be ascribed to advancements in hemostatic products, the increasing adoption of robotic-assisted surgeries, the proliferation of outpatient surgical centers, the integration of AI within healthcare, and the rising demand for biodegradable hemostats. Noteworthy trends for the forecast period include the application of minimally invasive surgical techniques, the ongoing development of advanced hemostatic materials, the implementation of point-of-care hemostasis monitoring, the incorporation of AI into surgical planning, and the availability of eco-friendly and sustainable surgical supplies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/surgical-hemostats-global-market-report

What Significant Factors Are Influencing The Surgical Hemostats Market Expansion?

The increasing occurrence of trauma cases is projected to boost the growth of the surgical hemostats market. Trauma is characterized as a physical injury or emotional shock resulting from a distressing or harmful event, impacting an individual’s body or mind. The rise in trauma cases primarily stems from an increase in road traffic accidents, which frequently cause severe injuries necessitating urgent medical intervention. Surgical hemostats are vital for swiftly and efficiently controlling bleeding during trauma incidents, thereby minimizing blood loss and stabilizing patients for subsequent medical care. For instance, in 2023, data from the Wisconsin Department of Health Services, a US-based government agency, indicated that traumatic injuries caused by assault grew by 3% in 2023 compared to 2022, climbing from 1,544 cases to 1,584 cases. Thus, the escalating incidence of trauma cases is fueling the expansion of the surgical hemostats market.

Which Segments Define The Surgical Hemostats Market Segment Structure?

The surgical hemostats market covered in this report is segmented –

1) By Product Type: Topical Thrombin-Based Hemostats, Flowable Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Combination Hemostats, Other Product Types

2) By Formulation: Matrix And Gel Hemostats, Sponge Hemostats, Sheet And Pad Hemostats, Powder Hemostats

3) By Application: Neurological Surgery, Orthopedic Surgery, Cardiovascular Surgery, Gynecological Surgery, Trauma, Plastic Surgery, Other Applications

4) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

Subsegments:

1) By Topical Thrombin-Based Hemostats: Human Thrombin-Based Hemostats, Bovine Thrombin-Based Hemostats, Recombinant Thrombin-Based Hemostats, Formulations Gel, Spray, Powder, Sponge

2) By Flowable Hemostats: Gelatin Matrix With Thrombin, Collagen-Based Flowables, Synthetic Polymer-Based Flowables

3) By Collagen-Based Hemostats: Microfibrillar Collagen, Nonwoven Collagen Pads, Collagen Fleece Or Sheets

4) By Oxidized Regenerated Cellulose Based Hemostats: Woven Oxidized Regenerated Cellulose Fabric, Non-woven Oxidized Regenerated Cellulose Pads, Oxidized Regenerated Cellulose With Additives

5) By Gelatin-Based Hemostats: Gelatin Sponge, Gelatin Powder, Gelatin Foam With Thrombin

6) By Combination Hemostats: Gelatin + Thrombin, Collagen + Thrombin, Oxidized Regenerated Cellulose + Thrombin

7) By Other Product Types: Chitosan-Based Hemostats, Kaolin-Based Hemostats, Synthetic Peptide Hemostats, Plant-Derived Agents

What Trends Are Affecting The Direction Of The Surgical Hemostats Market?

Leading companies in the surgical hemostat market are concentrating on developing advanced solutions, such as room-temperature stable sealing patches, to improve bleeding control, optimize operating-room readiness, and address issues related to cold-chain storage. These room-temperature sealing patches are next-generation hemostatic pads designed to maintain full functionality without refrigeration, offering greater flexibility, faster deployment, and enhanced accessibility compared with traditional refrigerated or bulky sponge-based hemostats. For instance, in May 2025, Baxter International Inc., a US-based healthcare company, unveiled the Hemopatch Sealing Hemostat RT, its latest collagen-based patch intended for efficient hemostasis in both open and minimally invasive procedures. The patch integrates a biodegradable bovine-dermis collagen matrix with a thin NHS-PEG layer that creates a hydrogel upon contact with fluids, enabling rapid tissue adhesion and sealing while also promoting natural platelet activity. Delivering hemostasis typically within about two minutes, biocompatibility, and complete resorption within 6–8 weeks, the product also provides practical benefits such as room-temperature storage and an extended 36-month shelf life, thereby improving surgical workflow and supply-chain flexibility.

Who Are The Established Players Within The Surgical Hemostats Market?

Major companies operating in the surgical hemostats market are Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies Inc, PerkinElmer Inc, Mettler Toledo International Inc, Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd, JEOL Ltd, Anton Paar GmbH, Renishaw plc, Metrohm AG, Genedata AG, HunterLab Europe GmbH, Avantes B V, JASCO Corporation, Wasatch Photonics Inc, Lablicate GmbH, StellarNet Inc, LabWare Inc, SciY Software GmbH

Get The Full Surgical Hemostats Market Report:

https://www.thebusinessresearchcompany.com/report/surgical-hemostats-global-market-report

Which Region Is The Top Contributor To The Surgical Hemostats Market By Share?

North America was the largest region in the surgical hemostats market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Surgical Hemostats Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/surgical-hemostats-global-market-report

Browse Through More Reports Similar to the Global Surgical Hemostats Market 2026, By The Business Research Company

Hemostasis Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Hemostasis Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Absorbable Hemostats Market Report 2026

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Surgical Hemostats Market Projected To Reach By 2030?

The surgical hemostats market size has demonstrated strong expansion in recent years. This market is set to increase from $3.93 billion in 2025 to $4.2 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.9%. The market’s historical development can be ascribed to an increase in surgical procedures, the necessity for blood loss management, innovations in surgical instruments, an expansion of hospital infrastructure, and greater awareness regarding patient safety.

The surgical hemostats market is anticipated to undergo substantial expansion in the upcoming years. It is projected to achieve a size of $5.41 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.5%. The expansion during this forecast timeframe can be ascribed to advancements in hemostatic products, the increasing adoption of robotic-assisted surgeries, the proliferation of outpatient surgical centers, the integration of AI within healthcare, and the rising demand for biodegradable hemostats. Noteworthy trends for the forecast period include the application of minimally invasive surgical techniques, the ongoing development of advanced hemostatic materials, the implementation of point-of-care hemostasis monitoring, the incorporation of AI into surgical planning, and the availability of eco-friendly and sustainable surgical supplies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/surgical-hemostats-global-market-report

What Significant Factors Are Influencing The Surgical Hemostats Market Expansion?

The increasing occurrence of trauma cases is projected to boost the growth of the surgical hemostats market. Trauma is characterized as a physical injury or emotional shock resulting from a distressing or harmful event, impacting an individual’s body or mind. The rise in trauma cases primarily stems from an increase in road traffic accidents, which frequently cause severe injuries necessitating urgent medical intervention. Surgical hemostats are vital for swiftly and efficiently controlling bleeding during trauma incidents, thereby minimizing blood loss and stabilizing patients for subsequent medical care. For instance, in 2023, data from the Wisconsin Department of Health Services, a US-based government agency, indicated that traumatic injuries caused by assault grew by 3% in 2023 compared to 2022, climbing from 1,544 cases to 1,584 cases. Thus, the escalating incidence of trauma cases is fueling the expansion of the surgical hemostats market.

Which Segments Define The Surgical Hemostats Market Segment Structure?

The surgical hemostats market covered in this report is segmented –

1) By Product Type: Topical Thrombin-Based Hemostats, Flowable Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Combination Hemostats, Other Product Types

2) By Formulation: Matrix And Gel Hemostats, Sponge Hemostats, Sheet And Pad Hemostats, Powder Hemostats

3) By Application: Neurological Surgery, Orthopedic Surgery, Cardiovascular Surgery, Gynecological Surgery, Trauma, Plastic Surgery, Other Applications

4) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

Subsegments:

1) By Topical Thrombin-Based Hemostats: Human Thrombin-Based Hemostats, Bovine Thrombin-Based Hemostats, Recombinant Thrombin-Based Hemostats, Formulations Gel, Spray, Powder, Sponge

2) By Flowable Hemostats: Gelatin Matrix With Thrombin, Collagen-Based Flowables, Synthetic Polymer-Based Flowables

3) By Collagen-Based Hemostats: Microfibrillar Collagen, Nonwoven Collagen Pads, Collagen Fleece Or Sheets

4) By Oxidized Regenerated Cellulose Based Hemostats: Woven Oxidized Regenerated Cellulose Fabric, Non-woven Oxidized Regenerated Cellulose Pads, Oxidized Regenerated Cellulose With Additives

5) By Gelatin-Based Hemostats: Gelatin Sponge, Gelatin Powder, Gelatin Foam With Thrombin

6) By Combination Hemostats: Gelatin + Thrombin, Collagen + Thrombin, Oxidized Regenerated Cellulose + Thrombin

7) By Other Product Types: Chitosan-Based Hemostats, Kaolin-Based Hemostats, Synthetic Peptide Hemostats, Plant-Derived Agents

What Trends Are Affecting The Direction Of The Surgical Hemostats Market?

Leading companies in the surgical hemostat market are concentrating on developing advanced solutions, such as room-temperature stable sealing patches, to improve bleeding control, optimize operating-room readiness, and address issues related to cold-chain storage. These room-temperature sealing patches are next-generation hemostatic pads designed to maintain full functionality without refrigeration, offering greater flexibility, faster deployment, and enhanced accessibility compared with traditional refrigerated or bulky sponge-based hemostats. For instance, in May 2025, Baxter International Inc., a US-based healthcare company, unveiled the Hemopatch Sealing Hemostat RT, its latest collagen-based patch intended for efficient hemostasis in both open and minimally invasive procedures. The patch integrates a biodegradable bovine-dermis collagen matrix with a thin NHS-PEG layer that creates a hydrogel upon contact with fluids, enabling rapid tissue adhesion and sealing while also promoting natural platelet activity. Delivering hemostasis typically within about two minutes, biocompatibility, and complete resorption within 6–8 weeks, the product also provides practical benefits such as room-temperature storage and an extended 36-month shelf life, thereby improving surgical workflow and supply-chain flexibility.

Who Are The Established Players Within The Surgical Hemostats Market?

Major companies operating in the surgical hemostats market are Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies Inc, PerkinElmer Inc, Mettler Toledo International Inc, Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd, JEOL Ltd, Anton Paar GmbH, Renishaw plc, Metrohm AG, Genedata AG, HunterLab Europe GmbH, Avantes B V, JASCO Corporation, Wasatch Photonics Inc, Lablicate GmbH, StellarNet Inc, LabWare Inc, SciY Software GmbH

Get The Full Surgical Hemostats Market Report:

https://www.thebusinessresearchcompany.com/report/surgical-hemostats-global-market-report

Which Region Is The Top Contributor To The Surgical Hemostats Market By Share?

North America was the largest region in the surgical hemostats market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Surgical Hemostats Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/surgical-hemostats-global-market-report

Browse Through More Reports Similar to the Global Surgical Hemostats Market 2026, By The Business Research Company

Hemostasis Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Hemostasis Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Absorbable Hemostats Market Report 2026

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Surgical Hemostats Market Projected To Reach By 2030?

The surgical hemostats market size has demonstrated strong expansion in recent years. This market is set to increase from $3.93 billion in 2025 to $4.2 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.9%. The market’s historical development can be ascribed to an increase in surgical procedures, the necessity for blood loss management, innovations in surgical instruments, an expansion of hospital infrastructure, and greater awareness regarding patient safety.

The surgical hemostats market is anticipated to undergo substantial expansion in the upcoming years. It is projected to achieve a size of $5.41 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.5%. The expansion during this forecast timeframe can be ascribed to advancements in hemostatic products, the increasing adoption of robotic-assisted surgeries, the proliferation of outpatient surgical centers, the integration of AI within healthcare, and the rising demand for biodegradable hemostats. Noteworthy trends for the forecast period include the application of minimally invasive surgical techniques, the ongoing development of advanced hemostatic materials, the implementation of point-of-care hemostasis monitoring, the incorporation of AI into surgical planning, and the availability of eco-friendly and sustainable surgical supplies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/surgical-hemostats-global-market-report

What Significant Factors Are Influencing The Surgical Hemostats Market Expansion?

The increasing occurrence of trauma cases is projected to boost the growth of the surgical hemostats market. Trauma is characterized as a physical injury or emotional shock resulting from a distressing or harmful event, impacting an individual’s body or mind. The rise in trauma cases primarily stems from an increase in road traffic accidents, which frequently cause severe injuries necessitating urgent medical intervention. Surgical hemostats are vital for swiftly and efficiently controlling bleeding during trauma incidents, thereby minimizing blood loss and stabilizing patients for subsequent medical care. For instance, in 2023, data from the Wisconsin Department of Health Services, a US-based government agency, indicated that traumatic injuries caused by assault grew by 3% in 2023 compared to 2022, climbing from 1,544 cases to 1,584 cases. Thus, the escalating incidence of trauma cases is fueling the expansion of the surgical hemostats market.

Which Segments Define The Surgical Hemostats Market Segment Structure?

The surgical hemostats market covered in this report is segmented –

1) By Product Type: Topical Thrombin-Based Hemostats, Flowable Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Combination Hemostats, Other Product Types

2) By Formulation: Matrix And Gel Hemostats, Sponge Hemostats, Sheet And Pad Hemostats, Powder Hemostats

3) By Application: Neurological Surgery, Orthopedic Surgery, Cardiovascular Surgery, Gynecological Surgery, Trauma, Plastic Surgery, Other Applications

4) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

Subsegments:

1) By Topical Thrombin-Based Hemostats: Human Thrombin-Based Hemostats, Bovine Thrombin-Based Hemostats, Recombinant Thrombin-Based Hemostats, Formulations Gel, Spray, Powder, Sponge

2) By Flowable Hemostats: Gelatin Matrix With Thrombin, Collagen-Based Flowables, Synthetic Polymer-Based Flowables

3) By Collagen-Based Hemostats: Microfibrillar Collagen, Nonwoven Collagen Pads, Collagen Fleece Or Sheets

4) By Oxidized Regenerated Cellulose Based Hemostats: Woven Oxidized Regenerated Cellulose Fabric, Non-woven Oxidized Regenerated Cellulose Pads, Oxidized Regenerated Cellulose With Additives

5) By Gelatin-Based Hemostats: Gelatin Sponge, Gelatin Powder, Gelatin Foam With Thrombin

6) By Combination Hemostats: Gelatin + Thrombin, Collagen + Thrombin, Oxidized Regenerated Cellulose + Thrombin

7) By Other Product Types: Chitosan-Based Hemostats, Kaolin-Based Hemostats, Synthetic Peptide Hemostats, Plant-Derived Agents

What Trends Are Affecting The Direction Of The Surgical Hemostats Market?

Leading companies in the surgical hemostat market are concentrating on developing advanced solutions, such as room-temperature stable sealing patches, to improve bleeding control, optimize operating-room readiness, and address issues related to cold-chain storage. These room-temperature sealing patches are next-generation hemostatic pads designed to maintain full functionality without refrigeration, offering greater flexibility, faster deployment, and enhanced accessibility compared with traditional refrigerated or bulky sponge-based hemostats. For instance, in May 2025, Baxter International Inc., a US-based healthcare company, unveiled the Hemopatch Sealing Hemostat RT, its latest collagen-based patch intended for efficient hemostasis in both open and minimally invasive procedures. The patch integrates a biodegradable bovine-dermis collagen matrix with a thin NHS-PEG layer that creates a hydrogel upon contact with fluids, enabling rapid tissue adhesion and sealing while also promoting natural platelet activity. Delivering hemostasis typically within about two minutes, biocompatibility, and complete resorption within 6–8 weeks, the product also provides practical benefits such as room-temperature storage and an extended 36-month shelf life, thereby improving surgical workflow and supply-chain flexibility.

Who Are The Established Players Within The Surgical Hemostats Market?

Major companies operating in the surgical hemostats market are Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies Inc, PerkinElmer Inc, Mettler Toledo International Inc, Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd, JEOL Ltd, Anton Paar GmbH, Renishaw plc, Metrohm AG, Genedata AG, HunterLab Europe GmbH, Avantes B V, JASCO Corporation, Wasatch Photonics Inc, Lablicate GmbH, StellarNet Inc, LabWare Inc, SciY Software GmbH

Get The Full Surgical Hemostats Market Report:

https://www.thebusinessresearchcompany.com/report/surgical-hemostats-global-market-report

Which Region Is The Top Contributor To The Surgical Hemostats Market By Share?

North America was the largest region in the surgical hemostats market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Surgical Hemostats Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/surgical-hemostats-global-market-report

Browse Through More Reports Similar to the Global Surgical Hemostats Market 2026, By The Business Research Company

Hemostasis Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Hemostasis Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Absorbable Hemostats Market Report 2026

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Surgical Hemostats Market By 2030 Starting From Its 2026 Size?

The size of the surgical hemostats market has experienced robust growth in recent years. This market is projected to expand from $3.93 billion in 2025 to $4.2 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.9%. The market’s historical expansion can be attributed to factors such as an increase in surgical procedures, the growing need for blood loss management, progress in surgical instruments, the development of hospital infrastructure, and increased awareness regarding patient safety.

The surgical hemostats market is projected to experience robust expansion over the coming years. This sector is anticipated to reach a valuation of $5.41 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.5%. This projected increase during the forecast period is driven by factors such as advancements in hemostatic solutions, the increasing use of robotic-assisted surgical procedures, the expansion of outpatient surgical facilities, the incorporation of artificial intelligence in healthcare, and the rising need for biodegradable hemostats. Prominent developments anticipated during this timeframe encompass the widespread adoption of minimally invasive surgical approaches, the creation of sophisticated hemostatic materials, real-time hemostasis monitoring at the point of care, the integration of AI into surgical planning processes, and a shift towards environmentally friendly and sustainable surgical products.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25916&type=smp

What Drivers Are Shaping The Future Growth Of The Surgical Hemostats Market?

An anticipated expansion of the surgical hemostats market is linked to the increasing occurrence of trauma cases. Trauma is defined as a physical injury or mental shock resulting from a distressing or damaging incident, impacting either an individual’s physical body or psychological state. The growing frequency of trauma cases largely stems from a surge in road traffic accidents, which often result in serious injuries that necessitate immediate medical treatment. During trauma incidents, surgical hemostats are instrumental in swiftly and efficiently managing bleeding, thereby reducing blood loss and preparing patients for subsequent medical care. For example, data from the Wisconsin Department of Health Services, a US-based government agency, indicates that in 2023, traumatic injuries resulting from assault saw a 3% increase over 2022, climbing from 1,544 cases to 1,584 cases. Consequently, the increased occurrence of trauma cases is fueling the expansion of the surgical hemostats market.

Which Segment Categories Define The Surgical Hemostats Market?

The surgical hemostats market covered in this report is segmented –

1) By Product Type: Topical Thrombin-Based Hemostats, Flowable Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Combination Hemostats, Other Product Types

2) By Formulation: Matrix And Gel Hemostats, Sponge Hemostats, Sheet And Pad Hemostats, Powder Hemostats

3) By Application: Neurological Surgery, Orthopedic Surgery, Cardiovascular Surgery, Gynecological Surgery, Trauma, Plastic Surgery, Other Applications

4) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

Subsegments:

1) By Topical Thrombin-Based Hemostats: Human Thrombin-Based Hemostats, Bovine Thrombin-Based Hemostats, Recombinant Thrombin-Based Hemostats, Formulations Gel, Spray, Powder, Sponge

2) By Flowable Hemostats: Gelatin Matrix With Thrombin, Collagen-Based Flowables, Synthetic Polymer-Based Flowables

3) By Collagen-Based Hemostats: Microfibrillar Collagen, Nonwoven Collagen Pads, Collagen Fleece Or Sheets

4) By Oxidized Regenerated Cellulose Based Hemostats: Woven Oxidized Regenerated Cellulose Fabric, Non-woven Oxidized Regenerated Cellulose Pads, Oxidized Regenerated Cellulose With Additives

5) By Gelatin-Based Hemostats: Gelatin Sponge, Gelatin Powder, Gelatin Foam With Thrombin

6) By Combination Hemostats: Gelatin + Thrombin, Collagen + Thrombin, Oxidized Regenerated Cellulose + Thrombin

7) By Other Product Types: Chitosan-Based Hemostats, Kaolin-Based Hemostats, Synthetic Peptide Hemostats, Plant-Derived Agents

What Major Market Trends Are Driving Changes In The Surgical Hemostats Market?

Leading companies in the surgical hemostat market are concentrating on developing advanced solutions, such as room-temperature-stable sealing patches. This effort aims to improve bleeding control, optimize operating-room readiness, and address issues related to cold-chain storage. These innovative room-temperature sealing patches are next-generation hemostatic pads designed to maintain full functionality without refrigeration, providing greater flexibility, quicker deployment, and enhanced accessibility compared to traditional refrigerated or bulky sponge-based hemostats. For instance, in May 2025, Baxter International Inc., a US-based healthcare company, introduced the Hemopatch Sealing Hemostat RT, its latest collagen-based patch engineered for efficient hemostasis in both open and minimally invasive procedures. This patch integrates a biodegradable bovine-dermis collagen matrix with a thin NHS-PEG layer, which forms a hydrogel upon contact with fluids, enabling rapid tissue adhesion and sealing while promoting natural platelet activity. The product typically achieves hemostasis within about two minutes, is biocompatible, and fully resorbs within 6–8 weeks. It also offers practical benefits like room-temperature storage and an extended 36-month shelf life, thereby improving surgical workflow and supply-chain flexibility.

Who Are The Top Companies Competing In The Surgical Hemostats Market?

Major companies operating in the surgical hemostats market are Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies Inc, PerkinElmer Inc, Mettler Toledo International Inc, Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd, JEOL Ltd, Anton Paar GmbH, Renishaw plc, Metrohm AG, Genedata AG, HunterLab Europe GmbH, Avantes B V, JASCO Corporation, Wasatch Photonics Inc, Lablicate GmbH, StellarNet Inc, LabWare Inc, SciY Software GmbH

Read the full surgical hemostats market report here:

https://www.thebusinessresearchcompany.com/report/surgical-hemostats-global-market-report

Which Geographic Regions Are Influencing Demand In The Surgical Hemostats Market?

North America was the largest region in the surgical hemostats market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Surgical Hemostats Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25916&type=smp

Browse Through More Reports Similar to the Global Surgical Hemostats Market 2026, By The Business Research Company

Hemostasis Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Hemostasis Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Absorbable Hemostats Market Report 2026

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Surgical Hemostats Market?

The surgical hemostats market size has experienced robust growth in recent years. This market is projected to expand from $3.93 billion in 2025 to $4.2 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.9%. The market’s historical growth can be attributed to an increase in surgical procedures, the rising demand for effective blood loss management, continuous advancements in surgical instruments, an expansion in hospital infrastructure, and a heightened awareness about patient safety.

The surgical hemostats market is projected to experience robust expansion over the coming years. This market is anticipated to reach $5.41 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this growth during the forecast period include advancements in hemostatic products, the increasing adoption of robotic-assisted surgeries, the expansion of outpatient surgical centers, the incorporation of AI into healthcare, and a rising demand for biodegradable hemostats. Key trends anticipated within the same forecast timeframe encompass the prevalence of minimally invasive surgical techniques, the development of advanced hemostatic materials, enhanced point-of-care hemostasis monitoring, the integration of AI in surgical planning, and a shift towards eco-friendly and sustainable surgical supplies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25916&type=smp

What Drivers Are Supporting Technological Adoption In The Surgical Hemostats Market?

An increasing occurrence of trauma incidents is anticipated to boost the expansion of the surgical hemostats market in the future. Trauma is defined as a physical injury or emotional shock resulting from a distressing or damaging event, impacting an individual’s physical or mental well-being. The growing number of trauma cases largely stems from a surge in road traffic accidents, resulting in serious injuries that necessitate immediate medical care. Surgical hemostats play a crucial role in rapidly and efficiently managing bleeding in trauma situations, thereby reducing blood loss and stabilizing patients for subsequent treatment. For example, data from the Wisconsin Department of Health Services, a US-based government agency, indicates that in 2023, traumatic injuries caused by assault saw a 3% increase over 2022, climbing from 1,544 cases to 1,584 cases. Consequently, the increasing prevalence of trauma incidents is a key factor propelling the surgical hemostats market’s expansion.

What Segment Types Are Examined In The Surgical Hemostats Market?

The surgical hemostats market covered in this report is segmented –

1) By Product Type: Topical Thrombin-Based Hemostats, Flowable Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Combination Hemostats, Other Product Types

2) By Formulation: Matrix And Gel Hemostats, Sponge Hemostats, Sheet And Pad Hemostats, Powder Hemostats

3) By Application: Neurological Surgery, Orthopedic Surgery, Cardiovascular Surgery, Gynecological Surgery, Trauma, Plastic Surgery, Other Applications

4) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

Subsegments:

1) By Topical Thrombin-Based Hemostats: Human Thrombin-Based Hemostats, Bovine Thrombin-Based Hemostats, Recombinant Thrombin-Based Hemostats, Formulations Gel, Spray, Powder, Sponge

2) By Flowable Hemostats: Gelatin Matrix With Thrombin, Collagen-Based Flowables, Synthetic Polymer-Based Flowables

3) By Collagen-Based Hemostats: Microfibrillar Collagen, Nonwoven Collagen Pads, Collagen Fleece Or Sheets

4) By Oxidized Regenerated Cellulose Based Hemostats: Woven Oxidized Regenerated Cellulose Fabric, Non-woven Oxidized Regenerated Cellulose Pads, Oxidized Regenerated Cellulose With Additives

5) By Gelatin-Based Hemostats: Gelatin Sponge, Gelatin Powder, Gelatin Foam With Thrombin

6) By Combination Hemostats: Gelatin + Thrombin, Collagen + Thrombin, Oxidized Regenerated Cellulose + Thrombin

7) By Other Product Types: Chitosan-Based Hemostats, Kaolin-Based Hemostats, Synthetic Peptide Hemostats, Plant-Derived Agents

What Trends Are Driving The Growth Trajectory Of The Surgical Hemostats Market?

Leading companies in the surgical hemostat market are concentrating on creating innovative solutions, such as room-temperature-stable sealing patches. These innovations aim to improve bleeding management, optimize operating-room preparedness, and overcome difficulties linked to cold-chain storage. These room-temperature sealing patches are defined as advanced hemostatic pads designed to operate effectively without requiring refrigeration. They provide enhanced flexibility, quicker application, and better accessibility when contrasted with conventional refrigerated or large sponge-based hemostats. For example, in May 2025, Baxter International Inc., a US-based healthcare firm, launched the Hemopatch Sealing Hemostat RT. This new collagen-based patch is intended for effective hemostasis during both open and minimally invasive surgeries. The patch incorporates a biodegradable bovine-dermis collagen matrix and a thin NHS-PEG layer, which forms a hydrogel upon contact with fluids, facilitating quick tissue adhesion and sealing, and also encouraging natural platelet activity. Providing hemostasis generally within approximately two minutes, along with biocompatibility and complete resorption within 6–8 weeks, the product additionally offers practical benefits such as storage at room temperature and an extended 36-month shelf life. This enhances surgical workflow and supply-chain adaptability.

Who Are The Top-Performing Companies In The Surgical Hemostats Market In Recent Years?

Major companies operating in the surgical hemostats market are Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies Inc, PerkinElmer Inc, Mettler Toledo International Inc, Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd, JEOL Ltd, Anton Paar GmbH, Renishaw plc, Metrohm AG, Genedata AG, HunterLab Europe GmbH, Avantes B V, JASCO Corporation, Wasatch Photonics Inc, Lablicate GmbH, StellarNet Inc, LabWare Inc, SciY Software GmbH

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/surgical-hemostats-global-market-report

How Does The Surgical Hemostats Market Perform Across Major Global Regions?

North America was the largest region in the surgical hemostats market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Surgical Hemostats Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25916&type=smp

Browse Through More Reports Similar to the Global Surgical Hemostats Market 2026, By The Business Research Company

Hemostasis Diagnostic Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Hemostasis Products Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Absorbable Hemostats Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Surgical Hemostats Industry In 2025?

The surgical hemostats market has demonstrated robust expansion over recent years. It is anticipated to grow from $3.68 billion in 2024 to $3.93 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.9%. The historical progression of this market can be attributed to an increase in surgical procedures, a higher incidence of trauma and accidents, an expanding geriatric population, the rising adoption of minimally invasive surgeries, and an increasing prevalence of chronic diseases.

The surgical hemostats market size is anticipated to demonstrate significant expansion in the upcoming period. This market is set to reach $5.09 billion by 2029, achieving a compound annual growth rate (CAGR) of 6.6%. Factors contributing to this growth during the forecast timeframe include a heightened need for sophisticated wound closure solutions, an increase in ambulatory surgical facilities, a greater inclination towards biodegradable hemostatic agents, an expanding application of combination hemostatic products, and a growing occurrence of lifestyle-related ailments necessitating surgical intervention. Key trends for the forecast period encompass technological progress in absorbable hemostatic materials, the incorporation of technology into robotic surgical procedures, the creation of advanced hemostatic formulations, synergy with intelligent surgical instruments, and novel developments in hemostatics derived from plants.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25916&type=smp

What Are The Drivers Pushing New Developments In The Surgical Hemostats Market?

The expanding occurrence of trauma incidents is anticipated to fuel the growth of the surgical hemostats market moving forward. Trauma refers to a physical injury or emotional shock caused by a harmful or distressing event, which can impact a person’s body or mind. The increased frequency of trauma cases is primarily attributable to a rise in road traffic accidents, resulting in severe injuries that demand urgent medical intervention. Surgical hemostats are instrumental in controlling bleeding swiftly and effectively during trauma scenarios, minimizing blood loss and stabilizing patients for further medical care. For instance, in 2023, according to the Wisconsin Department of Health Services, a US-based government agency, traumatic injuries caused by assault rose by 3% compared to 2022, increasing from 1,544 cases to 1,584 cases. Therefore, the rising incidence of trauma cases is propelling the growth of the surgical hemostats market.

What Are The Key Segments In The Surgical Hemostats Market?

The surgical hemostats market covered in this report is segmented –

1) By Product Type: Topical Thrombin-Based Hemostats, Flowable Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Combination Hemostats, Other Product Types

2) By Formulation: Matrix And Gel Hemostats, Sponge Hemostats, Sheet And Pad Hemostats, Powder Hemostats

3) By Application: Neurological Surgery, Orthopedic Surgery, Cardiovascular Surgery, Gynecological Surgery, Trauma, Plastic Surgery, Other Applications

4) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

Subsegments:

1) By Topical Thrombin-Based Hemostats: Human Thrombin-Based Hemostats, Bovine Thrombin-Based Hemostats, Recombinant Thrombin-Based Hemostats, Formulations Gel, Spray, Powder, Sponge

2) By Flowable Hemostats: Gelatin Matrix With Thrombin, Collagen-Based Flowables, Synthetic Polymer-Based Flowables

3) By Collagen-Based Hemostats: Microfibrillar Collagen, Nonwoven Collagen Pads, Collagen Fleece Or Sheets

4) By Oxidized Regenerated Cellulose Based Hemostats: Woven Oxidized Regenerated Cellulose Fabric, Non-woven Oxidized Regenerated Cellulose Pads, Oxidized Regenerated Cellulose With Additives

5) By Gelatin-Based Hemostats: Gelatin Sponge, Gelatin Powder, Gelatin Foam With Thrombin

6) By Combination Hemostats: Gelatin + Thrombin, Collagen + Thrombin, Oxidized Regenerated Cellulose + Thrombin

7) By Other Product Types: Chitosan-Based Hemostats, Kaolin-Based Hemostats, Synthetic Peptide Hemostats, Plant-Derived Agents

What Key Innovation Trends Are Fueling Advancements In The Surgical Hemostats Market?

Leading companies active in the surgical hemostat market are concentrating on creating enhanced products, leveraging innovative substances such as absorbable oxidized regenerated cellulose (ORC) to improve bleeding management and accelerate wound recovery. Absorbable oxidized regenerated cellulose, a plant-derived biodegradable material, is employed in surgical hemostats to regulate bleeding by establishing a physical barrier and encouraging clot formation at the wound site. For instance, in February 2022, Futura Surgicare Pvt. Ltd., an India-based medical device manufacturing company, introduced Hemostax, an advanced absorbable oxidized regenerated cellulose hemostat designed to effectively manage intraoperative bleeding. This product initiates hemostasis within 1.5 minutes and achieves its complete effect in 2 to 5 minutes. It is fully absorbable within 1 to 2 weeks, negating the requirement for its removal. The product is user-friendly, conforms well to diverse surgical locations, is non-toxic and biocompatible, and demonstrates antibacterial action against drug-resistant bacteria.

Who Are The Prominent Global Companies Shaping The Surgical Hemostats Market?

Major companies operating in the surgical hemostats market are Johnson And Johnson Services Inc., Medtronic plc, Becton Dickinson And Company, Stryker Corporation, Baxter International Inc., Teleflex Corporation, Integra LifeSciences Holdings Corporation., GELITA MEDICAL GmbH, B. Braun Melsungen AG, Advanced Medical Solutions Group plc, Axio Biosolutions Pvt. Ltd., Marine Polymer Technologies Inc, Biom’up USA Inc, Lotus Surgicals Pvt. Ltd, Hemostasis LLC, Biocer Entwicklungs-GmbH, CuraMedical BV, EndoClot Plus Inc, Starch Medical Inc, Tricol Biomedical Inc

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/surgical-hemostats-global-market-report

Which Region Is Projected To Lead The Surgical Hemostats Market During The Forecast Period?

North America was the largest region in the surgical hemostats market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Surgical Hemostats Market Report:

https://www.thebusinessresearchcompany.com/customise?id=25916&type=smp

Browse Through More Reports Similar to the Global Surgical Hemostats Market 2025, By The Business Research Company

Hemostats Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

Hemostasis Diagnostic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Hemostasis Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The Surgical Hemostats Market In The Coming Years?

The market size for surgical hemostats has significantly expanded over the past few years. Projected growth depicts an increase from $3.68 billion in 2024 to $3.93 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.9%. The growth experienced during the historic period can be credited to several factors. These include a rise in surgical procedures, increased occurrences of accidents and trauma, a growing elderly population, higher acceptance of minimally invasive surgeries, and an increased prevalence of chronic diseases.

The market for surgical hemostats is poised for significant expansion in the coming years, projecting a growth to the tune of $5.09 billion by 2029, with a compound annual growth rate (CAGR) of 6.6%. The predicted advancement can be attributed to factors such as the surging demand for sophisticated wound closure supplies, an increase in the number of outpatient surgical centers, a favorable tilt towards biodegradable hemostats, escalating utilization of combination hemostatic agents, and a rising prevalence of lifestyle diseases necessitating surgery. The forecast period is also expected to see certain key trends such as advancements in technology related to absorbable hemostats, the incorporation of technology in robot-assisted surgeries, the development of future-generation hemostatic formulations, the synchronization with intelligent surgical devices, and innovations in plant-based hemostatics.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25916&type=smp

Which Growth Drivers Are Shaping The Surgical Hemostats Market Outlook?

The surge in instances of trauma is anticipated to prompt an upswing in the surgical hemostats market. Trauma signifies both physical harm or psychological distress resulting from a destructive or detrimental occurrence, and it can bear an impact on an individual’s physical or mental health. The escalation in trauma cases primarily arises from a growth in vehicular accidents, causing grave wounds necessitating immediate medical response. Surgical hemostats are advantageous in rapidly and appropriately curbing bleeding during traumatic situations, reducing blood loss and stabilizing patients for subsequent treatment. As an illustration, data from the Wisconsin Department of Health Services – a U.S.-based government entity – shows that in 2023, the number of traumatic injuries due to assaults climbed by 3%, from 1,544 cases in 2022 to 1,584 cases. Consequently, the escalating number of trauma incidences is propelling the growth of the surgical hemostats market.

What Is The Segment Breakdown Of The Surgical Hemostats Market?

The surgical hemostats market covered in this report is segmented –

1) By Product Type: Topical Thrombin-Based Hemostats, Flowable Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Combination Hemostats, Other Product Types

2) By Formulation: Matrix And Gel Hemostats, Sponge Hemostats, Sheet And Pad Hemostats, Powder Hemostats

3) By Application: Neurological Surgery, Orthopedic Surgery, Cardiovascular Surgery, Gynecological Surgery, Trauma, Plastic Surgery, Other Applications

4) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

Subsegments:

1) By Topical Thrombin-Based Hemostats: Human Thrombin-Based Hemostats, Bovine Thrombin-Based Hemostats, Recombinant Thrombin-Based Hemostats, Formulations Gel, Spray, Powder, Sponge

2) By Flowable Hemostats: Gelatin Matrix With Thrombin, Collagen-Based Flowables, Synthetic Polymer-Based Flowables

3) By Collagen-Based Hemostats: Microfibrillar Collagen, Nonwoven Collagen Pads, Collagen Fleece Or Sheets

4) By Oxidized Regenerated Cellulose Based Hemostats: Woven Oxidized Regenerated Cellulose Fabric, Non-woven Oxidized Regenerated Cellulose Pads, Oxidized Regenerated Cellulose With Additives

5) By Gelatin-Based Hemostats: Gelatin Sponge, Gelatin Powder, Gelatin Foam With Thrombin

6) By Combination Hemostats: Gelatin + Thrombin, Collagen + Thrombin, Oxidized Regenerated Cellulose + Thrombin

7) By Other Product Types: Chitosan-Based Hemostats, Kaolin-Based Hemostats, Synthetic Peptide Hemostats, Plant-Derived Agents

How Are Global Trends Impacting The Development Of The Surgical Hemostats Market?

Key players in the surgical hemostat market are making strides towards creating improved products by using innovative materials like absorbable oxidized regenerated cellulose (ORC), with the aim to better manage bleeding and speed up the healing process of wounds. Absorbable oxidized regenerated cellulose is a naturally occurring, biodegradable substance used in surgical hemostats, which controls bleeding by creating a physical barrier and encouraging clot formation at the wound location. In February 2022, for example, Futura Surgicare Pvt. Ltd., a medical device manufacturer based in India, introduced Hemostax, an advanced hemostat made of absorbable oxidized regenerated cellulose that effectively manages intraoperative bleeding. The product kickstarts hemostasis within 1.5 minutes and reaches complete effectiveness between 2 to 5 minutes. The product is fully absorbed within a period of 1 to 2 weeks, eliminating the need for it to be removed. Furthermore, the product is user-friendly, adapts well to various surgical areas, is non-toxic and biocompatible, and has the ability to combat drug-resistant bacteria.

Who Are The Major Stakeholders Operating In The Surgical Hemostats Market?

Major companies operating in the surgical hemostats market are Johnson And Johnson Services Inc., Medtronic plc, Becton Dickinson And Company, Stryker Corporation, Baxter International Inc., Teleflex Corporation, Integra LifeSciences Holdings Corporation., GELITA MEDICAL GmbH, B. Braun Melsungen AG, Advanced Medical Solutions Group plc, Axio Biosolutions Pvt. Ltd., Marine Polymer Technologies Inc, Biom’up USA Inc, Lotus Surgicals Pvt. Ltd, Hemostasis LLC, Biocer Entwicklungs-GmbH, CuraMedical BV, EndoClot Plus Inc, Starch Medical Inc, Tricol Biomedical Inc

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/surgical-hemostats-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Surgical Hemostats Market?

North America was the largest region in the surgical hemostats market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=25916&type=smp

Browse Through More Reports Similar to the Global Surgical Hemostats Market 2025, By The Business Research Company

Absorbable Hemostats Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Non Surgical Cosmetic Procedures Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-surgical-cosmetic-procedures-global-market-report

Surgical Hooks Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/surgical-hooks-global-market-report

About The Business Research Company:

With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What CAGR Is Anticipated for the Surgical Hemostats Market Through 2029?

The market size of surgical hemostats has shown considerable expansion in the past few years, with forecasts predicting it will increase from $3.68 billion in 2024 to $3.93 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.9%. This substantial growth observed in the historical period can be explained by an increase in the number of surgeries, an elevated rate of trauma and accidents, a growing older population, increased usage of minimally invasive surgical procedures, and a heightened frequency of chronic diseases.

The market size for surgical hemostats is projected to experience significant growth in the upcoming years, expanding to $5.09 billion in 2029 with a compound annual growth rate (CAGR) of 6.6%. This growth during the forecasted period can be attributed to factors such as a higher demand for advanced products for wound closure, an increase in the number of ambulatory surgical centers, a growing preference for biodegradable hemostats, the expanded use of combination hemostatic agents, and a surge in the occurrence of lifestyle diseases that require surgery. Some prominent trends projected during the forecast period include advancements in technology within absorbable hemostats, the inclusion of technology in robotic surgeries, the development of next-generation hemostatic formulations, incorporation with smart surgical devices, and innovations within plant-based hemostatics.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25916&type=smp

What Market Forces Are Driving The Surgical Hemostats Sector In 2025 And Beyond?

The surgical hemostats market is predicted to grow due to an increase in trauma cases. Trauma, which can involve both physical injury and emotional distress, is typically a result of distressing or harmful incidents that can impact an individual’s mental or physical health. This increase in trauma cases is mostly being driven by an escalation in road traffic accidents, which can result in severe injuries that necessitate immediate medical attention. Surgical hemostats play a crucial role in managing bleeding quickly and efficiently during these trauma situations, thereby reducing blood loss and stabilizing the patient for further medical procedures. The Wisconsin Department of Health Services, a US governmental body, stated that in 2023, there was a 3% increase in traumatic injuries caused by assault, rising from 1,544 in 2022 to 1,584 cases. Consequently, the rising frequency of trauma cases is fueling the expansion of the surgical hemostats market.

How Is The Global Surgical Hemostats Market Categorized By Segments?

The surgical hemostats market covered in this report is segmented –

1) By Product Type: Topical Thrombin-Based Hemostats, Flowable Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Combination Hemostats, Other Product Types

2) By Formulation: Matrix And Gel Hemostats, Sponge Hemostats, Sheet And Pad Hemostats, Powder Hemostats

3) By Application: Neurological Surgery, Orthopedic Surgery, Cardiovascular Surgery, Gynecological Surgery, Trauma, Plastic Surgery, Other Applications

4) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

Subsegments:

1) By Topical Thrombin-Based Hemostats: Human Thrombin-Based Hemostats, Bovine Thrombin-Based Hemostats, Recombinant Thrombin-Based Hemostats, Formulations Gel, Spray, Powder, Sponge

2) By Flowable Hemostats: Gelatin Matrix With Thrombin, Collagen-Based Flowables, Synthetic Polymer-Based Flowables

3) By Collagen-Based Hemostats: Microfibrillar Collagen, Nonwoven Collagen Pads, Collagen Fleece Or Sheets

4) By Oxidized Regenerated Cellulose Based Hemostats: Woven Oxidized Regenerated Cellulose Fabric, Non-woven Oxidized Regenerated Cellulose Pads, Oxidized Regenerated Cellulose With Additives

5) By Gelatin-Based Hemostats: Gelatin Sponge, Gelatin Powder, Gelatin Foam With Thrombin

6) By Combination Hemostats: Gelatin + Thrombin, Collagen + Thrombin, Oxidized Regenerated Cellulose + Thrombin

7) By Other Product Types: Chitosan-Based Hemostats, Kaolin-Based Hemostats, Synthetic Peptide Hemostats, Plant-Derived Agents

What Upcoming Trends Are Expected To Impact The Surgical Hemostats Market Globally?

Key players in the surgical hemostat industry are concentrating their efforts on producing improved products by employing novel materials such as absorbable oxidized regenerated cellulose (ORC) to improve bleed management and accelerate the wound healing process. This eco-friendly material, derived from plants, is used in surgical hemostats for bleeding control; it works by creating a physical barricade and fostering blood clot formation at the injury site. For example, in February 2022, Futura Surgicare Pvt. Ltd., a medical device manufacturing company based in India, introduced Hemostax, a state-of-the-art absorbable oxidized regenerated cellulose hemostat devised to efficiently manage intraoperative bleeding. Hemostax can instigate hemostasis within 1.5 minutes and fully activate in just 2 to 5 minutes. It is completely absorbed within 1 to 2 weeks, thus eliminating the necessity for removal. It is user-friendly, adaptable to various surgical locations, non-poisonous, biocompatible, and displays antibacterial characteristics against drug-resistant bacteria.

Which Firms Are Considered Leaders In The Surgical Hemostats Market Space?

Major companies operating in the surgical hemostats market are Johnson And Johnson Services Inc., Medtronic plc, Becton Dickinson And Company, Stryker Corporation, Baxter International Inc., Teleflex Corporation, Integra LifeSciences Holdings Corporation., GELITA MEDICAL GmbH, B. Braun Melsungen AG, Advanced Medical Solutions Group plc, Axio Biosolutions Pvt. Ltd., Marine Polymer Technologies Inc, Biom’up USA Inc, Lotus Surgicals Pvt. Ltd, Hemostasis LLC, Biocer Entwicklungs-GmbH, CuraMedical BV, EndoClot Plus Inc, Starch Medical Inc, Tricol Biomedical Inc

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/surgical-hemostats-global-market-report

What Role Do Regional Policies And Investments Play In Surgical Hemostats Market Expansion?

North America was the largest region in the surgical hemostats market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25916&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model